ResMed

manufacturer of CPAP masks, machines and products that diagnose, treat or help manage respiratory conditions

RMD NYSE · home listing RMD Australian Securities Exchange ISIN US7611521078 SEC CIK 943819
Follow ResMed Weekly email: filings, results

Financials

Reported figures only · latest: Q1 2027 USD · US GAAP
Revenue, last quarter $1.4B +5.9% vs same quarter last year
Net income $418.4M +20% vs same quarter last year
EPS, diluted $2.92 +23.2% vs same quarter last year
Operating cash flow $422.4M −7.6% vs same quarter last year
Revenue by quarter
$1.3B
$1.3B
$1.3B
$1.3B
$1.4B
$1.4B
$1.5B
$1.4B
Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26 Q4 26 Q1 27

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
$0$2B$4B$6BFY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearRevenueNet income
FY26$5.7B$1.5B
FY25$5.1B$1.4B
FY24$4.7B$1B
FY23$4.2B$898M
FY22$3.6B$779M
FY21$3.2B$474.5M
FY20$3B$621.7M
FY19$2.6B$404.6M
FY18$2.3B$315.6M
FY17$2.1B$342.3M
FY16$1.8B$352.4M
FY15$1.7B$352.9M
FY14$1.6B$345.3M
FY13$1.5B$307.1M
FY12$1.4B$254.9M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
0%20%40%60%80%FY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearGross marginOperating marginNet margin
FY2661.1%33.4%26.9%
FY2559.4%32.7%27.2%
FY2456.7%28.2%21.8%
FY2355.8%26.8%21.3%
FY2256.6%28%21.8%
FY2157.5%28.3%14.8%
FY2058.1%27.4%21%
FY1957.3%22.2%15.5%
FY1857%23.2%13.5%
FY1758.1%20.6%16.6%
FY1658%23.3%19.2%
FY1560.2%24.4%21%
FY1463.7%26.1%22.2%
FY1362.1%23.4%20.3%
FY1260%21.5%18.6%
Free cash flowOperating cash flow minus capital expenditure
$0$500M$1B$1.5B$2BFY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearFree cash flow
FY26$1.6B
FY25$1.7B
FY24$1.3B
FY23$573.6M
FY22$216.3M
FY21$634M
FY20$706.9M
FY19$390.3M
FY18$442.4M
FY17$351.8M
FY16$489.4M
FY15$320.7M
FY14$318.5M
FY13$339.2M
FY12$336M
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$500M$1B$1.5BFY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearDividendsBuybacks
FY26$349.7M$700M
FY25$310.9M$300M
FY24$282.3M$150M
FY23$258.3M$0
FY22$245.3M$0
FY21$226.7M-
FY20$225.1M-
FY19$211.7M$22.8M
FY18$199.5M$53.8M
FY17$186.3M-
FY16$168.1M$102.1M
FY15$157.3M$160.3M
FY14$141.5M$202.2M
FY13$97.2M$186.3M
FY12-$392.7M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • ResMed
  • Healthcare median
−100%−50%0%50%FY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearResMedHealthcare median
FY2626.9%−11.1%
FY2527.2%−30.6%
FY2421.8%−47%
FY2321.3%−58%
FY2221.8%−80.4%
FY2114.8%−71.9%
FY2021%−62.2%
FY1915.5%−46.3%
FY1813.5%−49.6%
FY1716.6%−45.9%
FY1619.2%−36%
FY1521%−38.4%
FY1422.2%−35.5%
FY1320.3%−37.1%
FY1218.6%−29.1%